Journal Home
Search for

Volume 17, Issue 5, Pages 620-625 (September 2010)


View previous. 20 of 36 View next.

Narrow-Band Imaging in Diagnosis of Endometrial Cancer and Hyperplasia: A New Option?

Daniela Surico, MDaCorresponding Author Informationemail address, Alessandro Vigone, MDa, Daniele Bonvini, MDb, Raffaele Tinelli, MDc, Livio Leo, MDa, Nicola Surico, MDa

Received 1 July 2009; accepted 29 October 2009. published online 28 June 2010.

Abstract 

Study Objective

To estimate whether the use of narrow-band imaging (NBI) hysteroscopy increases concordance between visual identification and a histologic diagnosis of endometrial cancer and hyperplasia.

Design

Prospective study (Canadian Task Force classification: II-2).

Setting

Department of obstetrics and gynecology, University of Eastern Piedmont, Novara, Italy.

Patients

209 consecutive patients with abnormal uterine bleeding.

Interventions

White-light hysteroscopy and NBI hysteroscopy followed by direct biopsy.

Measurements and Main Results

The sensitivity and specificity of conventional hysteroscopy in predicting a diagnosis of cancer and hyperplasia were, respectively, 84.21% (95% confidence interval [CI], 79.27–89.15) and 99.47% (95% CI, 98.49–100.0), and 64.86% (95% CI, 58.39–71.34) and 98.77% (95% CI, 97.27–100.0), and of NBI hysteroscopy were 94.74% (95% CI, 91.71–97.76) and 97.89% (95% CI, 95.95–99.84), and 78.38% (95% CI, 72.8–83.96) and 97.67% (95% CI, 96.63–99.72). The concordance of conventional and NBI hysteroscopy with the histopathologic findings (measured using the Cohen κ) was, respectively, 88.80% (95% CI, 86.2%–96.3%) and 91.78% (95% CI, 89.6%–98.2%), a difference of 2.98% (95% CI, 0–9) in favor of NBI.

Conclusion

Narrow-band imaging hysteroscopy can accurately predict a histologic diagnosis of endometrial cancer or hyperplasia.

a Advanced Gynecological Oncology Centre, Departments of Obstetrics and Gynecology, Novara, Italy

b Clinical and Experimental Medicine–Epidemiology, University of Eastern Piedmont, Novara, Italy

c Department of Obstetrics and Gynecology, Sant'Anna Institute, Brescia, Italy

Corresponding Author InformationCorresponding author: Daniela Surico, MD, Departments of Obstetrics and Gynecology, Ospedale Maggiore della Carità, Viale Mazzini 18, 28100 Novara, Italy.

 The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.

PII: S1553-4650(09)01239-4

doi:10.1016/j.jmig.2009.10.014


View previous. 20 of 36 View next.